Objective-Aortic stenosis (AS) shares risk factors with atherosclerotic vascular disease. Carotid intima-media thickness (IMT) and plaque may reflect the cumulative damage from exposure to different atherosclerotic risk factors. We examined the relationship of carotid IMT and plaque with incident AS in a prospective population-based study. Approach and Results-A random sample of participants (age, 45-68 years) in the population-based Malmö Diet and Cancer Study underwent B-mode ultrasound with measurements of IMT and the presence of plaque in the common carotid artery (n=5079). Potential risk factors for incident AS were studied in age-and sex-adjusted and expanded multivariable-adjusted Cox regression models. A total of 69 (1.4%) participants developed AS during up to 20 years of follow-up. Significant risk factors for AS in age-and sex-adjusted analyses were (P<0.05) body mass index, low-density lipoprotein cholesterol, hypertension, diabetes mellitus, smoking, C-reactive protein, plaque, and IMT. In contrast, highdensity lipoprotein cholesterol, triglycerides, height, and leukocyte count were not significantly associated with AS (P>0.05). After adjustments, IMT, plaque, age, smoking, C-reactive protein, low-density lipoprotein cholesterol, and diabetes mellitus remained significantly associated with incident AS. IMT was no longer significantly associated with AS after adjustments for plaque and systolic blood pressure, but plaque remained significantly associated with incident AS. Conclusions-Traditional cardiovascular risk factors were individually associated with incident AS, and in multivariable models low-density lipoprotein cholesterol, smoking, age, presence of plaque, C-reactive protein, and diabetes mellitus remained significant predictors of incident AS. AS represents a vascular disorder related to carotid plaque, with potential implications for the pathophysiology and prevention of this disease. (Arterioscler Thromb Vasc Biol. 2014;34:2343-2348 .) The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
A ortic valve stenosis is the most common valve disease requiring surgical valve replacement in Western countries 1 and is associated with substantial morbidity and mortality, especially after onset of symptoms. 2, 3 Valve stenosis can be corrected by surgical or percutaneous valve replacement, but valve replacement is associated with a non-negligible risk for complications and mortality. 1 However, there are currently no medical treatment options for aortic stenosis (AS). Effective methods to prevent or delay progression of AS are therefore warranted.
Calcific aortic valve disease is currently the predominant cause of AS in developed countries. 1 Previously calcific AS was considered an unavoidable consequence of age-related wear and tear, but recent studies indicate that AS is an active degenerative disease process, similar to atherosclerosis. 4, 5 Several studies have suggested that coronary artery disease and AS share the same risk factors and a large proportion of patients with AS also have atherosclerotic coronary or peripheral artery disease. [6] [7] [8] [9] [10] [11] Furthermore, histopathologic studies of early valve lesions have shown deposition of lipoproteins in regions of early leaflet remodeling and calcification 5 and transgenic animal models have demonstrated that genetic induction of hypercholesterolemia leads to a calcific phenotype that can be arrested with reversion to normal cholesterol levels. 12 Carotid intima-media thickness (IMT) relates to the 2 innermost layers of the arterial wall: the intima and the media. The intima can thicken locally both in the presence of atherosclerosis because of pathophysiological processes associated with this disease (ie, lipid streaks and plaque) and as an adaptive process with alterations in collagen distribution, not related to atherosclerosis. 13, 14 Increased IMT however largely reflects medial hypertrophy and is often a result of aging and hypertension, particularly in the common carotid artery. 15 The presence of atherosclerotic plaques that are typically located in the carotid bifurcation can also be measured with B-mode ultrasound and is often a manifestation of atherosclerosis. 16, 17 IMT is a risk marker for stroke and acute myocardial infarction but results are conflicting as to the added value of IMT to other established risk factors. [18] [19] [20] [21] [22] [23] [24] [25] It has been postulated that common carotid artery IMT might also be a surrogate marker of coronary artery disease. 26 An association between IMT and aortic valve sclerosis has been established previously, 27 but it remains unclear whether the association applies to incident AS.
Our aim was to test the association of conventional cardiovascular risk factors, carotid IMT measures, and the presence of carotid plaque with incident AS. To our knowledge, no prospective population-based studies have examined the relationship between vascular ultrasound measurements and AS.
Materials and Methods
Material and Methods are available in the online-only Supplement.
Results

Baseline Characteristics
During a follow-up time of up to 20 years (mean, 16.5 years), 69 (1.4%) of the 5079 participants in the IMT samples were diagnosed with incident AS. The baseline characteristics across quartiles of IMT are shown in Table 1 and were similar to those for the entire Malmö Diet and Cancer Study (MDCS) cohort ( Table I in the online-only Data Supplement) .
The range of IMT was 0.33 to 1.82 mm in women and 0.33 to 2.03 mm in men. Age, body mass index (BMI), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, C-reactive protein (CRP), and leukocytes were positively associated with increasing IMT. Prevalence of hypertension and diabetes mellitus increased with increasing IMT. Smoking did not have a clear linear increase with increasing IMT.
Age-and Sex-Adjusted Analyses
We observed a significant association between IMT in the common carotid artery and incident AS (hazard ratio [HR], 1.46 per 1-SD increment; P<0.01) as shown in Table 2 . BMI, lowdensity lipoprotein cholesterol, CRP, diabetes mellitus, smoking, and hypertension were also associated with incident AS (P<0.05). In contrast, no significant association was observed between incident AS and high-density lipoprotein cholesterol, triglycerides, height, or leukocyte count. Presence of plaque was also significantly associated with incident AS (HR, 2.42; P<0.01). In age-and sex-adjusted analysis of incident aortic valve replacement, a trend toward increased risk of incident aortic valve replacement with high IMT was observed, but not significant (HR, 1.23; 95% confidence interval [CI], 0.90-1.68; P=0. 19 ). Presence of plaque was, however, significantly associated with aortic valve replacement (HR, 2.83; 95% CI, 1.49-5.37; P<0.01).
Kaplan-Meier curves illustrating the incidence of AS across sex-specific quartiles of IMT and for subjects with and without carotid plaque are shown in the Figure. The curves showed a markedly higher incidence of AS in the highest quartile of IMT, compared with the other quartiles and for carotid plaque, compared with no carotid plaque. Baseline characteristics across sex-specific quartiles of IMT. SD is parenthesized for continuous variables and percentage of the population is parenthesized for categorical variables. CRP and triglycerides were not normally distributed and are therefore presented as median and interquartile range. BMI indicates body mass index; CRP, C-reactive protein; HDL-C, high-density lipoprotein cholesterol; IMT, intima-media thickness; IQ, interquartile; and LDL-C, low-density lipoprotein cholesterol.
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Multivariate Analyses
The significant risk factors from age-and sex-adjusted models were included in a multivariable-adjusted regression model ( Table 3 ). The association between IMT and incident AS remained significant (HR, 1.28; 95% CI, 1.01-1.62; P=0.04) when adjusting for potential confounders (age, sex, BMI, lowdensity lipoprotein cholesterol, CRP, smoking, hypertension, and diabetes mellitus). The presence of plaque in the carotid artery was also a significant predictor for incident AS after multivariable-adjustments (HR, 2.08; 95% CI, 1.27-3.42; P<0.01). Other significant risk factors were age, diabetes mellitus, smoking, and CRP for the IMT model and BMI in the model for carotid plaque (P<0.05). In the multivariate model, no significant association was observed with hypertension or sex.
In the fully adjusted model, the HR for incident aortic valve replacement was 1.10 (95% CI, 0.80-1.50; P=0.57) for IMT and 2.47 (95% CI, 1.29-4.74; P<0.01) for plaque.
When presence of plaque was added to the multivariate analysis, the association with IMT and incident AS was not statistically significant (HR, 1.20; 95% CI, 0.95-1.52; P=0.13). However, the presence of plaque was still significantly associated with incident AS (HR, 1.95; 95% CI, 1.17-3.22; P=0.01). Similarly, when participants with plaque were excluded from the multivariate analyses, IMT was not significantly associated with incident AS but a clear trend remained (HR, 1.32; 95% CI, 0.87-2.01; P=0.19; n=3393).
To explore the impact of alternative measures of blood pressure, we conducted additional analyses adjusting for antihypertensive treatment along with systolic blood pressure, mean arterial blood pressure, and pulse pressure as continuous variables, instead of hypertension. In these analyses, no significant association between IMT and AS was observed in the model adjusting for systolic blood pressure (HR, 1.23; 95% CI, 0.97-1.56; P=0.09), mean arterial blood pressure (HR, 1.26; 95% CI, 0.99-1.60; P=0.06), or pulse pressure (HR, 1.22; 95% CI, 0.96-1.55; P=0.10). However, the presence of plaque remained associated with incident AS when adjusting for systolic blood pressure (HR, 2.02; 95% CI, 1.23-3.31; P<0.01), mean arterial blood pressure (HR, 2.06; 95% CI, 1.26-3.39; P<0.01), or pulse pressure (HR, 2.01; 95% CI, 1.22-3.30; P<0.01).
Discussion
The present study evaluates the association among established cardiovascular risk factors, carotid IMT, and carotid plaque with incident AS in a middle-aged population. Consistently with previous studies age, BMI, smoking, diabetes mellitus, and CRP were independently associated with incident AS. [6] [7] [8] [9] Moreover, we observed significant associations of AS with IMT and of AS with presence of plaque. Both associations remained significant after adjustment for established factors associated with risk for AS and cardiovascular disease. However, in models including both IMT and plaque, only plaque remained significantly associated with AS. Furthermore, in models adjusting for different measures of blood pressure (including systolic blood pressure, mean arterial pressure, or pulse pressure) carotid plaque, but not IMT, remained associated with AS. Consistent but nonsignificant HRs with 95% CI and P values from age-and sex-adjusted Cox proportional hazards regression model. BMI indicates body mass index; CI, confidence interval; CRP, C-reactive protein; HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio; IMT, intima-media thickness; and LDL-C, low-density lipoprotein cholesterol. associations with IMT and plaque were observed with incident aortic valve replacement, a more rare outcome indicating severe valve disease.
The nonsignificant association of IMT with incident AS when plaque was added to the model or participants with plaque were excluded likely reflects the lack of statistical power in these analyses. In both cases, similar risk estimates and a trend toward increased risk for incident AS were noted for higher IMT. Similarly, in analyses adjusting for different measures of blood pressure, comparable risk estimates were observed but P values did not pass the significance threshold. The rationale for studying IMT independently of plaque is that different pathophysiological mechanisms have been proposed to underlie the 2 phenotypes. 28 Plaques typically occur in the carotid bifurcation 16, 17 and are considered to represent atherosclerotic disease, whereas IMT in the common carotid artery is thought to represent medial hypertrophy. However, IMT in the common carotid artery also reflects intimal thickening related to atherosclerosis to some extent, limiting statistical power to detect association with this measure independently of plaque. 13, 14 Evidence for association of AS with IMT independently of plaque will, therefore, likely need to come from larger, more well-powered studies.
Although the associations between IMT and plaque with the more rare outcome of incident aortic valve replacement did not pass the significance threshold, consistent risk estimates in this group of patients with more severe disease provide support for the validity of the our conclusions.
Association of high IMT with AS has been described previously in a case-control study from a hospital setting. 29 However, the present study is a prospective cohort study, which is free of many of the biases inherent to case series and case-control studies and our study, therefore, strengthen previous evidence. 30 Collectively, our study and the previous case-control study provide evidence for a role of the processes underlying high carotid IMT and atherosclerotic plaque in the pathophysiology of AS. Furthermore, our observations indicate that the risk for AS, similar to other manifestations of atherosclerosis, might be modifiable through early intervention. Previous studies have shown that lipid-lowering medications can reduce carotid IMT and plaque. 31, 32 However, studies with lipid-lowering medications have shown disappointing results in AS, failing to slow the progression of AS in 3 large randomized trials. [33] [34] [35] Therefore, lipid-lowering medications are currently not recommended with a primary indication to halt the progression of AS. 3, 36 Prior randomized trials for AS did, however, primarily enroll individuals with established valve disease (in most cases moderate or severe AS). More recently, human genetic studies have shown that genetically elevated low-density lipoprotein cholesterol and lipoprotein(a) are associated with aortic valve disease in humans, indicating that earlier intervention targeting these particles might prevent AS. 37 It may, therefore, be hypothesized that therapeutic interventions should to be initiated earlier in the disease process. Valve calcification, 38 bicuspid valves, 39 and the presence of carotid plaque are markers of high risk, which could help identifying subjects whom may benefit from lipid-lowering therapy. It is also possible that lifestyle interventions, such as diet modifications and exercise, could affect the incidence of AS.
This study has limitations that should be taken into consideration. First, our study relied on nationwide hospital registers for diagnostic information. However, AS diagnoses have been validated previously in these registers with a high predictive value (>90%), 37 indicating only limited impact of misclassification. Validation studies also found that most patients diagnosed with AS in this register had moderate to severe AS on diagnosis. Any underestimation of AS would not be expected to lead to biased associations but rather result in reduced power to detect a true association because some cases of less severe AS may have been missed. 37 Second, the current study constitutes a nested subcohort in population-based cohort with a participation rate of 40%, why adequate caution should be noted in extrapolating these results to the general population. However, the MDCS has been compared with the general population previously and has been shown to be representative, although with somewhat lower mortality. 40 Third, no baseline echocardiographic study was conducted in the present study, which might lead to prevalent AS being included in the study and thus the incidence presented in our study might not reflect the true incidence in the population. Fourth, IMT was only measured in the far wall of the right carotid artery, whereas other studies have measured IMT as the mean of measurements at different sites of both carotid arteries. However, previous studies have suggested limited differences in relation to cardiovascular events across various measures. 41 In addition, in a recent meta-analysis, the prediction of carotid IMT or vascular events was almost identical in the MDCS to other population-based studies measuring both sides. 21 Reproducibility of the IMT measurements in the MDCS has been shown to be good and both the intrareader and inter-reader variability was low. [42] [43] [44] Fifth, only brachial blood pressure was measured and no information about central blood pressure was available. Differences in central and peripheral blood pressures have been described; however, the likelihood of a substantial difference affecting our results on the population level is low.
Sixth, although our plaque definition was reproducible, 42-44 subsequent studies and consensus statements, such as the Mannheim consensus, have suggested different plaque definitions than ours. Our plaque definition was based on measurements from both the common carotid artery and the carotid bifurcation (ie, an IMT >1.2 mm in an area of ≥10 mm), whereas the IMT measures were done only in the common carotid artery. Only 18 (1.1%) subjects who were classified as having plaque had an IMT >1.5 mm in the common carotid artery, supporting the validity of our IMT measurements, which were unlikely to be confounded by plaque. Perhaps, however, the numbers of identified plaques would have differed between our method and Mannheim consensus, which should be acknowledged as a limitation when interpreting our results. Finally, as our study has a long follow-up time, regression dilution bias resulting from lack of repeated measurements and information on use of medications and lifestyle changes could play a role, 45 but would, perhaps, be expected to bias our results toward the null.
In conclusion, this present prospective, population-based study identified carotid IMT and plaque to be associated with increased risk for incident AS. When including both factors in a model, only plaque remained significantly associated with AS, indicating a role of atherosclerosis in the pathophysiology of AS. Our findings may have implications for the pathophysiology and prevention of this disease.
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